Seyoung Seo

991 total citations
46 papers, 676 citations indexed

About

Seyoung Seo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Seyoung Seo has authored 46 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Seyoung Seo's work include Palliative Care and End-of-Life Issues (8 papers), Lung Cancer Treatments and Mutations (6 papers) and HER2/EGFR in Cancer Research (5 papers). Seyoung Seo is often cited by papers focused on Palliative Care and End-of-Life Issues (8 papers), Lung Cancer Treatments and Mutations (6 papers) and HER2/EGFR in Cancer Research (5 papers). Seyoung Seo collaborates with scholars based in South Korea, United States and Japan. Seyoung Seo's co-authors include Sook Ryun Park, Baek‐Yeol Ryoo, Young Soo Park, Yoon‐Koo Kang, Min‐Hee Ryu, Ji‐Young Song, Richard Bayliss, Yangsoon Park, Seongsoo Jang and Sang Wan Kim and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Seyoung Seo

41 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seyoung Seo South Korea	15	369	294	217	112	84	46	676
Virginia Arrazubi Spain	12	372 1.0×	235 0.8×	136 0.6×	109 1.0×	155 1.8×	48	641
Hye Sook Han South Korea	19	352 1.0×	258 0.9×	229 1.1×	138 1.2×	141 1.7×	72	789
Sung Hoon Sim South Korea	18	493 1.3×	325 1.1×	243 1.1×	230 2.1×	131 1.6×	81	1.0k
Zhaoxu Zheng China	14	518 1.4×	236 0.8×	199 0.9×	156 1.4×	252 3.0×	52	799
A.R. Abdul Razak Canada	11	435 1.2×	283 1.0×	211 1.0×	75 0.7×	64 0.8×	26	760
Yanshuo Cao China	13	367 1.0×	181 0.6×	107 0.5×	153 1.4×	115 1.4×	37	581
Seung‐Hoon Beom South Korea	17	459 1.2×	361 1.2×	150 0.7×	110 1.0×	230 2.7×	69	901
Byoung Yong Shim South Korea	18	596 1.6×	359 1.2×	232 1.1×	182 1.6×	248 3.0×	110	1.0k
Eun‐Jung Jung South Korea	16	275 0.7×	208 0.7×	167 0.8×	114 1.0×	325 3.9×	86	823
Maria Ignez Braghiroli Brazil	14	583 1.6×	302 1.0×	210 1.0×	147 1.3×	230 2.7×	58	901

Countries citing papers authored by Seyoung Seo

Since Specialization

Citations

This map shows the geographic impact of Seyoung Seo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seyoung Seo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seyoung Seo more than expected).

Fields of papers citing papers by Seyoung Seo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seyoung Seo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seyoung Seo. The network helps show where Seyoung Seo may publish in the future.

Co-authorship network of co-authors of Seyoung Seo

This figure shows the co-authorship network connecting the top 25 collaborators of Seyoung Seo. A scholar is included among the top collaborators of Seyoung Seo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seyoung Seo. Seyoung Seo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeong, Hyehyun, Yousun Ko, Kyung Won Kim, et al.. (2025). Longitudinal changes in body composition during palliative systemic chemotherapy and survival outcomes in metastatic colorectal cancer. World Journal of Gastrointestinal Oncology. 17(5). 103479–103479.

Seo, Seyoung, et al.. (2024). Factors Affecting Life-Sustaining Treatment Decisions and Changes in Clinical Practice after Enforcement of the Life-Sustaining Treatment (LST) Decision Act: A Tertiary Hospital Experience in Korea. Cancer Research and Treatment. 57(1). 280–288.

Koh, Younsuck, Min Sun Kim, Sanghee Kim, et al.. (2024). Amendment Proposals for the Act on Decisions on Life-Sustaining Treatment to Improve End-of-Life Care. Korean Journal of Medical Ethics. 27(2). 51–70. 1 indexed citations

Kang, Jung Hun, Kyung Hee Lee, Seong Hoon Shin, et al.. (2024). Efficacy of transdermal buprenorphine patch for managing withdrawal symptoms in patients with cancer physically dependent on prescription opioids. The Oncologist. 29(11). e1593–e1603. 1 indexed citations

Kang, EunKyo, Jung Hun Kang, Su‐Jin Koh, et al.. (2024). Early Integrated Palliative Care in Patients With Advanced Cancer. JAMA Network Open. 7(8). e2426304–e2426304. 15 indexed citations

Seo, Seyoung, Bhumsuk Keam, Seong Hoon Shin, et al.. (2023). A phase Ia/Ib study of novel anti‐ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer. International Journal of Cancer. 153(8). 1501–1511. 4 indexed citations

Kim, Jwa Hoon, Changhoon Yoo, Seyoung Seo, et al.. (2022). A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY. Cancers. 14(3). 559–559. 16 indexed citations

Seo, Seyoung, et al.. (2021). Comparison of Sinusoidal Obstruction Syndrome in Gastric Cancer Patients Receiving S-1/oxaliplatinVersusCapecitabine/oxaliplatin. Anticancer Research. 41(1). 391–402. 2 indexed citations

Kim, S-B., Bhumsuk Keam, Seong Hoon Shin, et al.. (2020). 928P Phase I dose-expansion (part II) study of ISU104 (a novel anti-ErbB3 monoclonal antibody) alone and combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Annals of Oncology. 31. S667–S668. 3 indexed citations

10.

Kim, Jwa Hoon, Seyoung Seo, Kyu‐pyo Kim, et al.. (2020). Rivaroxaban Versus Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer. In Vivo. 34(2). 829–837. 14 indexed citations

11.

Choi, Junyoung, Shinkyo Yoon, Deokhoon Kim, et al.. (2019). Transglutaminase 2 induces intrinsic EGFR-TKI resistance in NSCLC harboring EGFR sensitive mutations.. PubMed. 9(8). 1708–1721. 5 indexed citations

12.

Choi, Junyoung, Shinkyo Yoon, Deokhoon Kim, et al.. (2019). Transglutaminase 2 Induces Intrinsic EGFR-TKI Resistance in NSCLC Harboring EGFR Sensitive Mutations. SSRN Electronic Journal. 3 indexed citations

13.

Seo, Seyoung, Min‐Hee Ryu, Baek‐Yeol Ryoo, et al.. (2019). Clinical significance of MET gene amplification in metastatic or locally advanced gastric cancer treated with first-line fluoropyrimidine and platinum combination chemotherapy. Chinese Journal of Cancer Research. 31(4). 620–631. 9 indexed citations

14.

Seo, Seyoung, Min‐Hee Ryu, Young Soo Park, et al.. (2018). Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3). Gastric Cancer. 22(3). 527–535. 112 indexed citations

15.

Lee, Dae Ho, Seyoung Seo, Eun Kyung Cho, et al.. (2017). P2.03a-038 Phase III Trial of Pemetrexed/Carboplatin vs Pemetrexed Only in Chemo-Naïve Elderly Non-SQCC NSCLC Patients Aged ≥ 70. Journal of Thoracic Oncology. 12(1). S911–S911. 1 indexed citations

16.

Seo, Seyoung, Changhoon Yoo, Baek‐Yeol Ryoo, et al.. (2017). Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma. Journal of Digestive Diseases. 18(8). 480–486. 15 indexed citations

17.

Yang, Hannah, Mi-Hee Lee, Intae Park, et al.. (2017). HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2. Cancer Letters. 411. 19–26. 26 indexed citations

18.

Seo, Seyoung, Min‐Hee Ryu, Ji Yong Ahn, et al.. (2017). Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: Results of GASTric cancer HER2 reassessment study 3 (GASTHER3).. Journal of Clinical Oncology. 35(4_suppl). 27–27. 20 indexed citations

19.

Cheon, Jaekyung, Seyoung Seo, Jung Yong Hong, Dok Hyun Yoon, & Cheolwon Suh. (2016). Diagnostic Value of Unilateral Bone Marrow Biopsy in Diffuse Large B-Cell Lymphoma: Correlation to Bilateral Bone Marrow Biopsy and PET/CT Findings. Blood. 128(22). 1869–1869. 1 indexed citations

20.

Lubner, Sam Joseph, William R. Schelman, Daniel Mulkerin, et al.. (2010). Phase II study of oxaliplatin, high-dose capecitabine, and sorafenib in patients with advanced pancreatic cancer.. Journal of Clinical Oncology. 28(15_suppl). 4143–4143. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact